表观遗传学与妊娠期糖尿病:表观遗传流行病学研究综述及其在探索表观遗传中介与改善预测中的应用
本文综述了已发表的人体研究,探讨母体妊娠期糖尿病(GDM)、2型糖尿病、孕期空腹或负荷后血糖与任何表观遗传标记(DNA甲基化、组蛋白修饰或miRNA)的关联。共纳入81项相关研究,多数关注表观遗传机制在介导GDM对子代结局的宫内效应中的潜在作用。研究发现研究规模小(参与者中位数58例,GDM病例中位数27例),多数未尝试重复验证,最常见表观遗传指标为DNA甲基化。探索因果效应或对子代下游结局影响的研究缺乏,需要更稳健的方法探索表观遗传机制作为GDM暴露对未来肥胖和2型糖尿病风险可能中介的作用。识别表观遗传生物标志物以改善GDM及其相关不良结局风险识别的研究目前罕见,但可能有助于未来准确风险分层的工具。
要点
- 多数研究关注DNA甲基化介导GDM对子代结局的宫内效应,但证据规模小且缺乏重复验证。
- 探索表观遗传因果效应或对子代下游结局影响的研究缺乏,需更稳健方法。
- 识别GDM风险表观遗传生物标志物的研究罕见,但可能改善未来风险分层。
核心结论
- 表观遗传机制介导GDM对子代肥胖和2型糖尿病效应的假说缺乏证据,需更稳健方法探索因果中介。
- 识别GDM及其不良结局风险的表观遗传生物标志物研究罕见,但可能有助于未来准确风险分层。
研究设计与样本
- 综述已发表的人体研究,探索母体GDM、2型糖尿病、孕期空腹或负荷后血糖与任何表观遗传标记的关联。
- 共纳入81项相关研究,多数关注表观遗传机制介导GDM对子代结局的宫内效应。
- 研究规模小:参与者总数中位数58例,GDM病例中位数27例;多数未尝试重复验证。
主要发现
- 最常分析的表观遗传指标为DNA甲基化。
- 多数探索表观遗传中介的研究检查宫内GDM暴露与子代脐带血或婴儿血/胎盘DNA甲基化的关联。
- 探索因果效应或对子代下游结局影响的研究缺乏。
临床怎么用
- 目前证据不足以支持表观遗传机制作为GDM对子代肥胖和2型糖尿病风险的中介。
- 识别GDM风险表观遗传生物标志物的研究罕见,尚未可用于临床风险分层。
局限性
- 研究规模小(参与者中位数58例,GDM病例中位数27例)。
- 多数研究未尝试重复验证。
- 探索因果效应或对子代下游结局影响的研究缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epigenetics encapsulates a group of molecular mechanisms including DNA methylation, histone modification and microRNAs (miRNAs). Gestational diabetes (GDM) increases the risk of adverse perinatal outcomes and is associated with future offspring risk of obesity and type 2 diabetes. It has been hypothesised that epigenetic mechanisms mediate an effect of GDM on offspring adiposity and type 2 diabetes and this could provide a modifiable mechanism to reduce type 2 diabetes in the next generation. Evidence for this hypothesis is lacking. Epigenetic epidemiology could also contribute to reducing type 2 diabetes by identifying biomarkers that accurately predict risk of GDM and its associated future adverse outcomes. We reviewed published human studies that explored associations between any of maternal GDM, type 2 diabetes, gestational fasting or post-load glucose and any epigenetic marker (DNA methylation, histone modification or miRNA). Of the 81 relevant studies we identified, most focused on the potential role of epigenetic mechanisms in mediating intrauterine effects of GDM on offspring outcomes. Studies were small (median total number of participants 58; median number of GDM cases 27) and most did not attempt replication. The most common epigenetic measure analysed was DNA methylation. Most studies that aimed to explore epigenetic mediation examined associations of in utero exposure to GDM with offspring cord or infant blood/placenta DNA methylation. Exploration of any causal effect, or effect on downstream offspring outcomes, was lacking. There is a need for more robust methods to explore the role of epigenetic mechanisms as possible mediators of effects of exposure to GDM on future risk of obesity and type 2 diabetes. Research to identify epigenetic biomarkers to improve identification of women at risk of GDM and its associated adverse (maternal and offspring) outcomes is currently rare but could contribute to future tools for accurate risk stratification.
引用
- Elliott HR, Sharp GC, Relton CL, et al. Epigenetics and gestational diabetes: a review of epigenetic epidemiology studies and their use to explore epigenetic mediation and improve prediction. Diabetologia. 2019. PMID: 31624900. doi:10.1007/s00125-019-05011-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。